Overview

Botswana Study of UC-781 Vaginal Microbicide

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will test the safety, side effects, and acceptability of two strengths of UC-781 gel when used by women and men in Botswana for two weeks.
Phase:
Phase 1
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborator:
CONRAD
Treatments:
Anti-Infective Agents
UC-781